Floatz logo

VARINON

Breast Cancer

Alexandria UniversitySmall moleculePhase 4 / ApprovedActive
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
59/ 100

Competitive context

890 Active assets in the Breast Cancer cohort.

Asset / SponsorPhaseRating
Lapatinib
University of New Mexico
Phase 3BBB
Darolutamide
Vandana Abramson
Phase 2BBB
Trastuzumab Duocarmazine
Byondis B.V.
Phase 3BB
Palbociclib
Hoffmann-La Roche
Phase 4BB
TAMOXIFEN
Dana-Farber Cancer Institute
Phase 4BB

View all 50 →

Same molecule, other indications

VARINON is also rated in:

post-operative wound seroma, non-human animalDormant
BB
Indicative ·
69 / 100
View asset →
breast cancerDormant
BB
Indicative ·
68 / 100
View asset →
chronic venous insufficiencyDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →